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1. Introduction  
Rheumatoid arthritis is a systemic autoimmune disease characterized by chronic 
inflammation of multiple joints, with disruption of joint cartilage. Accumulating evidence 
has pointed to inflammatory cytokines inducing hyperplasia of synovial cells in joints as an 
etiology for rheumatoid arthritis. High concentrations of cytokines such as tumor necrosis 
factor- (TNF-) and interleukin-1 (IL-1) are found in synovial fluid and plasma from 
patients with rheumatoid arthritis (Eastgate et al., 1988; Saxne et al., 1998) and those 
cytokines produce matrix metalloproteinases or activate osteoclasts, causing irreversible 
damage to soft tissues and bones (Olsen & Stein, 2004). Challenges for rheumatoid arthritis 
treatment, therefore, have been attempted using TNF- inhibitors, anti-TNF antibodies, a 
soluble TNF receptor-fusion protein, or an IL-1 receptor antagonist. A concern with these 
therapies, however, are side effects such as serious infections and inducible malignant 
tumors (den Broeder et al., 2002). 
Resveratrol (Fig. 8), a phytoalexin that is present in grape skin and red wine, exerts a 
variety of actions to reduce superoxides, suppress carcinogenesis and angiogenesis, 
prevent diabetes mellitus, inhibit inflammation, and prolong life span (Elliott & Jirousek, 
2008). Furthermore, resveratrol decreases plaque formation relevant to neurodegenerative 
diseases such as Alzheimer’s disease and Huntington’s disease (Karuppagounder et al., 
2009). Of particular interest is that resveratrol is a potent and specific inhibitor of NF-B 
activation induced by TNF- or IL-1, and therefore, resveratrol might be a potential 
therapy for rheumatoid arthritis (Elmali et al., 2007; Molnar & Garai, 2005; Penberthy, 
2007).  
2. Materials and methods 
2.1 Cell culture 
MH7A human rheumatoid arthritis synovial cells were obtained from the Riken cell bank 
(Ibaraki, Japan). Cells were cultured in a culture medium; RPMI-1640 (Wako, Osaka, Japan) 
supplemented with 10% heat-inactivated fetal bovine serum (FBS), penicillin (final 
concentration, 100 U/ml), and streptomycin (final concentration, 0.1 mg/ml), in a 
humidified atmosphere of 5% CO2 and 95% air at 37°C. 
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2.2 Cell viability 
Cell viability was evaluated by the method of Mosmann (1983) using 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT). 
2.3 Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) 
assay 
MH7A cells were fixed with 4% paraformaldehyde. After inactivating endogenous 
peroxidase with methanol containing 0.3% H2O2, a Permeabilization Buffer (Takara Bio 
Inc., Otsu, Japan) was applied to cells and stood on ice for 5 min. Then, a Labeling 
Reaction Mixture (Takara Bio Inc.) was added and incubated in a humidified chamber at 
37°C for 60 min. Reactive cells were stained with 3% methyl green and detected with a 
light microscope.  
2.4 H2A phosphorylation assay 
MH7A cells were incubated in a chemiluminescence detection assay kit (Upstate, 
Charlottesville, Virginia, USA) and reacted with an anti-phospho-H2A.X (Ser139) followed 
by an anti-mouse-HRP conjugate. Phosphorylation of H2A.X at Ser139 was identified by 
staining with chemiluminescent HRP substrate LumiGLO, and signals were detected with a 
microplate luminometer (ARVO mx/light, Perkinelmer, Waltham, MA, USA). 
2.5 Assay of mitochondrial membrane potentials 
Mitochondrial membrane potentials were measured using a DePsipherTM kit. MH7A cells 
were untreated and treated with resveratrol (100 M) in the absence and presence of sirtinol 
(10 M) for 24 h. After washing with cold phosphate-buffered saline (PBS), cells were 
incubated in a DePsipherTM solution at 37°C for 20 min. Then, cells were washed with 1 ml 
of a reaction buffer containing a stabilizer solution. The fluorescent signals were observed 
with a laser scanning microscopes (LSM 510, Carl Zeiss Co., Ltd, Germany) equipped with 
an epifluorescence device using a fluorescein long-pass filter (fluorescein and rhodamine) at 
an absorbance of 590 nm for red aggregations and at an absorbance of 530 nm for green 
aggregations. 
2.6 Reverse transcription-polymerase chain reaction (RT-PCR) 
Total RNAs of MH7A cells before and after treatment with resveratrol (100 M) were 
purified by an acid/guanidine/thiocyanate/chloroform extraction method using a Sepasol-
RNA I Super kit (Nacalai Tesque, Kyoto, Japan). After purification, total RNAs were treated 
with RNase free-DNase I (2 unit) at 37°C for 30 min to remove genomic DNAs, and 10 g of 
RNAs were resuspended in water. Then, oligo dT primers, dNTP, 5 x First Strand buffer, 
and SuperScript III RNase H-Reverse Transcriptase were added to the RNA solution and 
incubated at 65°C for 5 min followed by 60°C for 1 min, 56°C for 60 min, 58°C for 60 min, 
85°C for 5 min to synthesize the first strand cDNA. Subsequently, 1 l of the reaction 
solution was diluted with water and mixed with 10 x PCR reaction buffer, dNTPs, MgCl2, 
oligonucleotide, dimethylsulfoxide [final concentration, 5% (v/v)] and 1 unit of Taq 
polymerase (Fermentas, St. Leon-Roth, Germany) (final volume, 20 l). RT-PCR was carried 
out with a Takara Thermal cycler Dice (Takara Bio Inc.) programmed as follows: the first 
one step, 94°C for 2 min and the ensuing 30 cycles, 94°C for 1 s, 62°C for 15 s, and 72°C for 
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30 s using primers shown in Table 1. PCR products were stained with ethidium bromide 




Sense primer Anti-sense primer Base 
pair 
Bad CTGGGGCTGTGGAGATCCGGAGTCGCC TCACTGGGAGGGGGCGGAGCTTCCCC 320 
Bak GAGCCCATTCCCACCATTCTACCT AGAGAGGAAGGGAGAGAACTGAGAGGAC 381 
Bax GGGAGACACCTGAGCTGACC GGACTCCAGCCACAAAGATGG 404 
Bcl-2 GAACTGGGGGAGGATTGTGGCC TCGACGTTTTGCCTGAAGACTGTTAA 486 
Bcl-XL AGGGAGGCAGGCGACGAGTTT TGAAGAGTGAGCCCAGCAGAACCA 421 
Sirtuin 1 ATTACTGAAAAACCTCCACGAACACAAAA GCCTACTAATCTGCTCCTTTGCCACTCT 379 
Table 1. Primers used for RT-PCR 
2.7 Real-time RT-PCR 
Total RNA was isolated from MH7A cells with Sepasol RNA I super kit (Nacalai Tesque, 
Kyoto, Japan). Total RNA (5 g) was reverse-transcribed to cDNA using the High Capacity 
cDNA Reverse Transcription kit (Applied Biosystems, Tokyo, Japan), and quantitative real-
time RT-PCR was performed with Applied Biosystems 7900HT real-time PCR system 
(Applied Biosystems, Foster City, CA, USA) using the SYBR Green realtime Master Mix 
(TOYOBO, Osaka, Japan) protocol. Primers used for real-time RT-PCR are shown in Table 2. 
The PCR cycling conditions were 95˚C for 4 min, followed by 40 cycles at 95˚C for 15 s and 
62˚C for 15 s and 72˚C for 45 s. A standard curve was made by amplifying 0.5, 1, 2, 4, and 8 
μl of the GAPDH mRNA diluted at 1:250. The mRNA quantity for each target gene was 
calculated from the standard curve using an SDS 2.1 Software (Applied Biosystems, Foster 




Sense primer Anti-sense primer 
Base 
pair 
AIF TCACAAAGACACTGCGATTCAAACAGT GTTGCTGAGGTATTCGGGGAGGAT 491 
FOXO-1 TATGGACACTTTGCGTTTCTTATTTAGGATAAC GGCAGAAGGGAGAATGAGATGAAGTATG 366 
FOXO-3 TGGATGCTGATGGGTTGGATTTTAA TGGTGCTGAGGGGTGCTGTCC 415 
P21 ACCGAGTGGGGGCATCATCAA GGATGGGGTGGATGAGGAAGGTC 534 
P27 CGTGGCTCGTCGGGGTCTGT CCCTTCTCCACCTCTTGCCACTC 393 
P53 GCCATCTACAAGCAGTCACAGCACAT GGCACAAACACGCACCTCAAAGC 348 
GAPDH GACTTCAACAGCGACACCCACTCC AGGTCCACCACCCTGTTGCTGTAG 128 
Table 2. Primers used for real-time RT-PCR 
2.8 Western blotting 
After treatment with resveratrol (100 M) for 6-24 h, MH7A cells were harvested and 
centrifuged at 600 x g for 10 min. After washing-out with 1 ml of PBS, the pellet was 
resuspended in 50 l of buffer A (20 mM Hepes, 10 mM KCl, 1.5 mM MgCI2, 1 mM EDTA, 1 
mM EGTA, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 250 mM sucrose, 
pH 7.5) and homogenized. The lysate was centrifuged at 1000 x g for 10 min and the 
supernatant was further centrifuged at 10000 x g for 1 h. The pellet and supernatant were 
regarded as the mitochondria- and cytosol-enriched fractions, respectively. Each fraction 
was loaded on 12% sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
and transferred to polyvinylidene difluoride membranes. Blotting membranes were blocked 
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with TTBS (150 mM NaCl, 0.05% Tween20, and 20 mM Tris, pH 7.5) containing 5% BSA and 
subsequently reacted with an anti-cytochrome c antibody (1:400) (Chemicon, Billerica, MA, 
USA), followed by an HRP-conjugated goat anti-mouse IgG antibody. Immunoreactivity 
was detected with an ECL kit (GE Healthcare, NJ, USA) and visualized using a 
chemiluminescence detection system (FUJIFILM, Tokyo, Japan). Signal density was 
measured with Image Gauge software (FUJIFILM, Tokyo, Japan).  
2.9 Enzymatic assay of caspase activity 
Caspase activation was measured using a caspase fluorometric assay kit (Ac-Asp-Glu-Val-
Asp-MCA for a caspase-3 substrate peptide; Ac-Ile-Glu-Thr-Asp-MCA for a caspase-8 
substrate peptide; and Ac-Leu-Glu-His-Asp-MCA for a caspase-9 substrate peptide).  
3. Results  
3.1 Resveratrol induces MH7A cell apoptosis 
In the MTT assay, resveratrol reduced MH7A cell viability in a concentration (1-200 M)- 
and treatment time (24-72 h)-dependent manner (Fig. 1A), suggesting that resveratrol 
induces MH7A cell death.  
Resveratrol increased TUNEL-positive cells in a concentration (100-200 M)-dependent 
manner (Fig. 1B), indicating that resveratrol induces MH7A cell apoptosis. DNA damage or 
apoptosis is recognized to stimulate phosphorylation of histone H2A.X. Resveratrol (100 
M) significantly enhanced H2A.X phosphorylation, the extent reaching approximately 13 
fold of control levels (Fig. 1C). This provides further evidence for resveratrol-induced 
MH7A cell apoptosis. 
3.2 Resveratrol disrupts mitochondrial membrane potentials in a sirtuin 1-dependent 
manner 
Resveratrol is shown to regulate mitochondrial functions or energy metabolism by 
interacting with NAD-dependent deacetylase sirtuin 1 (Kaeberlein et al., 2005; Lagouge et 
al., 2006). Interestingly, resveratrol-induced MH7A cell death was inhibited by sirtinol (10 
M), an inhibitor of sirtuin 1 (Fig. 2), suggesting that resveratrol induces MH7A cell death 
in a sirtuin 1-dependent manner. Moreover, the resveratrol effect was inhibited by 
tricostatin A (30 nM), an inhibitor of histone deacetylase (HDAC) (Fig. 2). This may 
account for the implication of sirtuin 1-regulated apoptosis-related gene transcription in 
the resveratrol effect.  
To see whether resveratrol-induced MH7A cell apoptosis is mediated via the mitochondria, 
mitochondrial membrane potentials were monitored. For untreated cells, orange-red 
fluorescent signals alone were found (Fig. 3A,B). In contrast, resveratrol (100 M) 
accumulated green fluorescent signals without orange-red fluorescent signal (Fig. 3C,D), 
indicating that resveratrol disrupts mitochondrial membrane potentials in MH7A cells. The 
resveratrol effect on mitochondrial membrane potentials was abolished by sirtinol (10 M) 
(Fig. 3E,F). This implies that resveratrol disrupts mitochondrial membrane potentials in 
MH7A cells under the control of sirtuin 1. Taken together, these results indicate that 
resveratrol induces MH7A cell apoptosis by damaging the mitochondria in a sirtuin 1-
dependent manner.  
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Fig. 1. Resveratrol induces apoptosis in MH7A cells. (A) MH7A cells were treated with 
resveratrol at concentrations as indicated for 24-72 h in serum-free culture medium, and cell 
viability was quantified with an MTT assay. In the graph, each point represents the mean (± 
SEM) percentage of basal levels (MTT intensities for cells untreated with resveratrol) (n=8). 
(B) Cells were treated with resveratrol at concentrations as indicated for 24 h in serum-free 
culture medium, and TUNEL-positive cells were counted. In the graph, each column 
represents the mean (± SEM) percentage of basal levels (TUNEL-positive cell numbers 
without resveratrol treatment) (n=3-6). P values, unpaired t-test. (C) Cells were treated with 
resveratrol at concentrations as indicated for 24 h in FBS-free culture medium, and H2A.X 
phosphorylation was quantified. In the graph, each column represents the mean (± SEM) 
ratio against basal levels (H2A.X phosphorylation without resveratrol treatment) (n=4). P 
values, unpaired t-test. 
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Fig. 2. Resveratrol-induced MH7A cell death is inhibited by a sirtuin 1 inhibitor or an HDAC 
inhibitor. MH7A cells were treated with resveratrol (100 M) in the absence and presence of 
sirtinol (10 M) or tricostatin A (TSA) (30 nM) for 48 h in serum-free culture medium, and 
cell viability was quantified with an MTT assay. In the graph, each column represents the 
mean (± SEM) percentage of basal levels (MTT intensities for cells untreated with any drug) 
(n=4). P values, unpaired t-test. 
 
 
Fig. 3. Resveratrol disrupts mitochondrial membrane potentials in a sirtuin 1-dependent 
manner. MH7A cells were treated with resveratrol (100 M) in the absence and presence of 
sirtinol (10 M) for 24 h in serum-free culture medium, and mitochondrial membrane 
potentials were monitored. (A,C,E) Orange-red fluorescent images at an absorbance of 590 
nm. (B,D,F) Green fluorescent images at an absorbance of 530 nm. Note that similar results 
were obtained with 3 independent experiments. 
In the RT-PCR analysis, resveratrol (100 M) increased expression of the sirtuin 1 mRNA in 
MH7A cells in a treatment time (20-60 min)-dependent manner (Fig. 4A). This points to 
sirtuin 1 being a significant target in resveratrol-induced MH7A cell death. Accumulating 
evidence has shown that resveratrol upregulates or downregulates expression of the Bcl-2 
family that includes Bcl-2 and Bcl-XL, to prevent from mitochondrial damage, and Bad, Bax, 
and Bak, to induce mitochondrial damage (Shakibaei et al., 2009). Resveratrol (100 M) 
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downregulated expression of the Bcl-XL mRNA in MH7A cells from 1-h through 3-h 
treatment (Fig. 4C), while it had no effect on expression of mRNAs for Bcl-2 (Fig. 4B), Bad 
(Fig. 4D), Bax (Fig. 4E), and Bak (Fig. 4F). Collectively, resveratrol may disrupt 
mitochondrial membrane potentials by reducing Bcl-XL expression through a pathway 
relevant to sirtuin 1-mediated transcription. 
 
 
Fig. 4. Resveratrol upregulates expression of the sirtuin 1 mRNA and downregulates 
expression of the Bcl-XL mRNA. MH7A cells were untreated (Control) and treated with 
resveratrol (100 M) for 20-60 min or 0.5-3 h in serum-free culture medium, and then RT-
PCR was carried out. In the graphs, each point represents the ratio against the intensity at 0 
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3.3 Resveratrol activates caspase-3 and -9 through mitochondrial damage in a sirtuin 
1-dependent manner 
Mitochondrial damage allows release of apoptosis-related factors including cytochrome c. In 
the Western blot analysis using the mitochondrial and cytosolic component from MH7A 
cells, resveratrol (100 M) increased presence of cytosolic cytochrome c in parallel with a 
treatment time (3-24 h)-dependent decrease in the presence of mitochondrial cytochrome c 
(Fig. 5). This suggests that resveratrol stimulates release of cytochrome c from the 
mitochondria into the cytosol. 
 
 
Fig. 5. Resveratrol stimulates cytochrome c release from the mitochondria. MH7A cells were 
treated with resveratrol (100 M) for 3-24 h in serum-free culture medium, followed by 
fractionation into the mitochondrial (M) and cytosolic component (C), and Western blotting 
was carried out. In the graph, each point represents the ratio against the immunoreactive 
intensity at 0 h for the mitochondrial component regarded as 1. cyto c, cytochrome c. Note 
that similar results were obtained with 3 independent experiments. 
In the enzymatic assay of caspase activity, resveratrol (100 M) significantly activated 
caspase-3 and -9, but no activation of caspase-8 was obtained (Fig. 6). Resveratrol-induced 
activation of caspase-3 and -9 was inhibited by sirtinol (10 M) (Fig. 6). Consequently, the 
results indicate that resveratrol activates caspase-9 and the effector caspase-3 in association 
with mitochondrial damage allowing cytochrome c release in a sirtuin-dependent manner, 
to induce MH7A cell apoptosis. 
Overall, resveratrol appears to downregulate Bcl-XL expression in a sirtuin 1-dependent 
manner, which promotes Bax-Bax complex, causing disruption of mitochondrial membrane 
potentials allowing cytochrome c release from the mitochondria. This is followed by activation 
of caspase-9 and the effector caspase-3, which, in turn, are responsible for apoptosis in MH7A 
human rheumatoid arthritis synovial cells (Nakayama et al., 2010) (Fig. 7). 
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Fig. 6. Resveratrol activates caspase-3 and -9 in a sirtuin 1-dependent manner. MH7A cells 
were treated with resveratrol (100 M) in the absence and presence of sirtinol (10 M) for 24 
h in serum-free culture medium, and caspase activities were assayed. In the graph, each 
column represents the mean (± SEM) ratio against basal levels (caspase activities for cells 
untreated with any drug) (n=4-6). P values, unpaired t-test. NS, not significant. 
 
 
Fig. 7. Pathway underlying resveratrol-induced apoptosis in MH7A human rheumatoid 
arthritis synovial cells. 
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3.4 Resveratrol induces MH7A cell apoptosis with higher potency 
We examined the effect of other polyphenols such as piceatannol, rhapontin, (-)-catechin, 
(+)-catechin, (-)-epicatechin, (-)-gallocatechin, (-)-epigallocatechin, (-)-catechin gallate, (-)-
epicatechin gallate, (-)-gallocatechin gallate, and (-)-epigallocatechin gallate on MH7A cell 
death (Fig. 8). Of these, piceatannol, rhapontin, (-)-gallocatechin, (-)-epigallocatechin, (-)-
catechin gallate, (-)-epicatechin gallate, (-)-gallocatechin gallate, and (-)-epigallocatechin 
gallate induced MH7A cell death in a concentration (10-100 M)- and treatment time (24-72 
h)-dependent manner, but with lesser potency than resveratrol, whilst no effect was 
observed for (-)-catechin, (+)-catechin, or (-)-epicatechin (Fig. 9). This indicates that 
resveratrol is capable of inducing apoptosis in MH7A human rheumatoid arthritis synovial 
cells, with much higher potency than other polyphenols. 
 
 
Fig. 8. Chemical structures of resveratrol and a variety of polyphenols. 
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Fig. 9. Effects of resveratrol and a variety of polyphenols on MH7A cell death. MH7A cells 
were treated with resveratrol and polyphenols as indicated at concentrations ranging from 
10-100 M for 24-72 h in serum-free culture medium, and cell viability was quantified with 
an MTT assay. In the graphs, each point represents the mean (± SEM) percentage of basal 
levels (MTT intensities for cells untreated with resveratrol or polyphenols) (n=8). 
3.5 Resveratrol increases expression of mRNAs for FOXO-1, FOXO-3, p21, p27, and 
AIF in MH7A cells 
Sirtuin 1 regulates apoptosis-related gene transcription mediated by FOXO or NF-κB 
(Giannakou & Partridge, 2004; Salminen & Kaarniranta, 2009). In support of this, resveratrol 
induces growth arrest and apoptosis by activating FOXO in prostate cancer cells (Chen et 
al., 2010). In the real-time RT-PCR analysis, resveratrol (100 M) increased expression of 
mRNAs both for FOXO-1 and FOXO-3 in MH7A cells in a bell-shaped treatment time (20-60 
min)-dependent manner, with the peak at 20-min treatment (Fig. 10A), indicating 
involvement of FOXO in resveratrol-induced MH7A cell apoptosis.  
Lines of studies have shown that resveratrol induces apoptosis in a variety of cells by 
activating p53 (Huang et al., 1999; Kuo et al., 2002; She et al., 2001). Resveratrol (100 M) 
here, however, had no effect on expression of the p53 mRNA in MH7A cells (Fig. 10B). This 
suggests that resveratrol induces MH7A cell apoptosis in a p53-independent manner. 
Resveratrol is shown to upregulate expression of p21 and p27 (Ganapathy et al., 2010; 
Ragione et al., 2003). Resveratrol (100 M) increased expression of mRNAs both for p21 and 
p27 still in MH7A cells in a bell-shaped treatment time (20-60 min)-dependent manner, with 
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the peak at 40-min treatment (Fig. 10B). This raises the possibility that resveratrol could 
suppress MH7A cell proliferation and growth by inhibiting cyclin-dependent protein 
kinases (Cdks) via control of p21 and p27. 
Apoptosis-inducing factor (AIF) is released from damaged mitochondria and causes 
chromatin condensation and large-scale (~50 kbp) DNA fragmentation, leading to caspase-
independent apoptosis. Interestingly, resveratrol induces apoptosis in human lung 
adenocarcinoma ASTC-a-1 cells through mitochondria-mediated AIF release (Zhang et al., 
2011). In the present study, a huge increase in the expression of the AIF mRNAs in MH7A 
cells was found after 40-min treatment with resveratrol (100 M) (Fig. 10C), suggesting that 





Fig. 10. Effects of resveratrol on mRNAs for FOXO-1, FOXO-3, p21, p27, p53, and AIF. 
MH7A cells were treated with resveratrol (100 M) for periods as indicated in serum-free 
culture medium, and then real-time RT-PCR was carried out. The mRNA quantity for each 
gene was calculated from the standard curve made by amplifying different amounts of the 
GAPDH mRNA, and normalized by regarding the average of independent basal mRNA 
quantity at 0 h as 1. In the graphs, each point represents the mean (± SEM) ratio (n=3 
independent experiments). 
4. Discussion 
Accumulating evidence has shown that resveratrol induces apoptosis or suppresses cell 
growth and proliferation by interacting with FOXO, NF-kB, and p53 involving wide-range 
of gene transcriptions such as those for apoptosis-related proteins, p21, p27, and AIF 
(Chen et al., 2010; Ganapathy et al., 2010; Huang et al., 1999; Kuo et al., 2002; Ragione et 
al., 2003; She et al., 2001). Notably, resveratrol is shown to increase expression of sirtuin 1, 
a mammalian NAD+-dependent deacetylase (class III HDAC) (Franco et al., 2010). In the 
present study, resveratrol upregulated expression of mRNAs for FOXO-1, FOXO-3, p21, 
p27, AIF, and sirtuin 1 in MH7A cells but otherwise downregulated expression of the Bcl-
XL mRNA, without affecting expression of mRNAs for p53, Bcl-2, Bad, Bax, or Bak. FOXO 
belongs to the O subclass of the forkhead family of transcription factors, which includes 
FOXO-1, FOXO-3, FOXO-4, and FOXO-6. Evidence has pointed to the role of sirtuin 1 in 
the regulation of apoptosis-related gene transcription mediated by FOXO or NF-B 
(Giannakou & Partridge, 2004; Salminen & Kaarniranta, 2009). FOXO and/or sirtuin 1, 
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therefore, may be a primary target of resveratrol-regulated apoptosis-related gene 
transcription. 
Resveratrol induced MH7A cell apoptosis in a concentration (1-200 M)- and treatment 
time (24-72 h)-dependent manner. Two major pathways for apoptosis are well-recognized, 
i.e., oxidative stress-induced mitochondria-mediated apoptotic pathway and endoplasmic 
reticulum (ER) stress-induced apoptotic pathway. For the former pathway, the Bcl-2 
family such as Bcl-2, Bcl-XL, Bad, and Bax plays a central role; Bcl-2 and Bcl-XL protect the 
mitochondria by capturing Bax, but Bad otherwise disrupts mitochondrial membrane 
potentials by releasing Bax from a Bcl-2/Bax complex or a Bcl-XL/Bax complex. Oxidative 
stress disrupts mitochondrial membrane potentials by making a Bax/Bax pore, thereby 
damaging the mitochondria to allow release of apoptosis-related proteins such as 
cytochrome c, AIF, Smac/DIABLO, Omi/HtrA2, and endonuclease G into the cytosol 
(Wang, 2001). Subsequently, released cytochrome c activates caspase-3 by forming an 
apoptosome complex together with apoptosis proteases activating factor-1 (Apaf-1) and 
caspase-9, leading to apoptosis (Wang, 2001). Resveratrol disrupted mitochondrial 
membrane potentials, stimulated cytochrome c release from the mitochondria into the 
cytosol, and activated caspase-3 and –9 in MH7A cells. This, taken together with the 
finding that resveratrol downregulated the Bcl-XL mRNA, accounts for mitochondria-
mediated caspase-dependent pathway in resveratrol-induced MH7A cell apoptosis. Of 
particular interest is that resveratrol-induced MH7A cell apoptosis, mitochondrial 
damage, and caspase-3/-9 activation were prevented by a sirtuin 1 inhibiter or an HDAC 
inhibitor. This confirms that sirtuin 1 is required for resveratrol-induced MH7A cell 
apoptosis. 
Findings by Byun et al. (2008) suggest that resveratrol induces apoptosis in fibroblast-like 
synoviocytes derived from patients with rheumatoid arthritis by activating caspase-8 as a 
primary target, which cleaves Bid, causing mitochondrial damage that triggers activation of 
caspase-9 and the effector caspase-3, without affecting the levels of Bax, Bcl-XL, and Bcl-2. 
This observation contrasts with our finding that resveratrol does not activate caspase-8 in 
MH7A cells (Nakayama et al., 2010). Thus, resveratrol-induced MH7A cell apoptosis may be 
mediated via a novel apoptotic pathway. 
In contrast, resveratrol upregulated expression of the AIF mRNA in MH7A cells. AIF 
induces apoptosis by causing chromatin condensation and DNA fragmentation. This 
suggests that resveratrol could induce MH7A cell apoptosis via an additional pathway, i.e., 
mitochondria-mediated caspase-independent pathway. 
Resveratrol also increased expression of the p21 and p27 mRNAs in MH7A cells. p21 and 
p27 are recognized to inhibit cyclin E/Cdk2 that proceeds cell growth at the G1 phase of cell 
cycling. Resveratrol, consequently, could suppress MH7A cell growth by inhibiting cyclin 
E/Cdk2 under the control of p21 and/or p27. 
Like resveratrol, some other polyphenols induced apoptosis in MH7A human rheumatoid 
arthritis synovial cells. Of polyphenols examined here resveratrol induced MH7A cell 
apoptosis with the highest potency. This implies that, of the polyphenols, resveratrol could 
be the best target for the development of new drugs for treating rheumatoid arthritis. 
In summary, the results of the present study show that resveratrol upregulates expression of 
FOXO and suirtuin 1 relevant to apoptosis-related gene transcription and its regulation in 
MH7A human rheumatoid arthritis synovial cells. Resveratrol downregulates expression of 
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the Bcl-XL mRNA, possibly mediated by FOXO, which causes disruption of mitochondrial 
membrane potentials, allowing cytochrome c release from the mitochondria into the cytosol, 
leading to activation of caspase-9 and the effector caspase-3 in a sirtuin 1-dependent 
manner. This represents a mitochondria-mediated caspase-dependent apoptotic pathway. 
Upregulation of the AIF mRNA by resveratrol, alternatively, suggests resveratrol-induced 
MH7A cell apoptosis via a mitochondria-mediated caspase-independent pathway. 
Moreover, upregulation of the p21 and p27 mRNAs by resveratrol may account for 
resveratrol-induced inhibition of MH7A cell growth. 
5. Conclusion 
Resveratrol induces apoptosis in MH7A human rheumatoid arthritis synovial cells, and 
does so with much higher potency than other polyphenols. It achieves this effect by 
decreasing Bcl-XL expression, which disrupts mitochondrial membrane potentials, allowing 
cytochrome c release from the mitochondria into the cytosol, thereby activating caspase-9 
and the effector caspase-3 in a sirtuin 1-dependent manner, which induces apoptosis. In 
addition, AIF, p21, and p27 may also participate in resveratrol-induced MH7A cell 
apoptosis and growth inhibition. These findings imply that resveratrol may be capable of 
preventing hyperplasia of synovial cells in human rheumatoid arthritis. Resveratrol, thus, 
could be developed as a promising drug for treatment of rheumatoid arthritis. 
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